JFNIX
Price
$81.99
Change
+$6.97 (+9.29%)
Updated
Feb 3 closing price
Net Assets
5.36B
RYCFX
Price
$44.45
Change
-$3.37 (-7.05%)
Updated
Feb 3 closing price
Net Assets
137.47M
Interact to see
Advertisement

JFNIX vs RYCFX

Header iconJFNIX vs RYCFX Comparison
Open Charts JFNIX vs RYCFXBanner chart's image
Janus Henderson Global Life Sciences I
Price$81.99
Change+$6.97 (+9.29%)
VolumeN/A
Net Assets5.36B
Rydex Biotechnology C
Price$44.45
Change-$3.37 (-7.05%)
VolumeN/A
Net Assets137.47M
JFNIX vs RYCFX Comparison Chart in %
View a ticker or compare two or three
VS
JFNIX vs. RYCFX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and RYCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 5.36B vs. RYCFX (137M). JFNIX pays higher dividends than RYCFX: JFNIX (0.45) vs RYCFX (0.00). JFNIX was incepted earlier than RYCFX: JFNIX (17 years) vs RYCFX (25 years). RYCFX (2.43) is less costly to investors than JFNIX (0.77). RYCFX is a more actively managed with annual turnover of: 79.00 vs. JFNIX (30.00). JFNIX (2500) and RYCFX (2500) have matching initial minimum investment requirements. JFNIX annual gain was more profitable for investors over the last year : 15.19 vs. RYCFX (4.56). JFNIX return over 5 years is better than : 15.70 vs. RYCFX (-43.73).
JFNIXRYCFXJFNIX / RYCFX
Total Expense Ratio0.772.3832%
Annual Report Gross Expense Ratio0.772.4332%
Fund Existence17 years25 years-
Gain YTD1.0233.13233%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets5.36B137M3,912%
Annual Yield % from dividends0.450.00-
Returns for 1 year15.194.56333%
Returns for 3 years23.89-9.30-257%
Returns for 5 years15.70-43.73-36%
Returns for 10 years99.38-21.73-457%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIZRX37.370.44
+1.19%
Nomura Opportunity R
NQGAX45.530.39
+0.86%
Nuveen Global Equity Income A
JHDAX19.98-0.08
-0.40%
JPMorgan Hedged Equity 2 A
RPMYX11.82-0.15
-1.25%
Reinhart International PMV Advisor
SSRRX6.73-0.09
-1.32%
Touchstone Small Company R6